Jim Cramer’s researcher, Nicole Urken, discusses why the ability for McDonald’s and Yum Brands to thrive in this environment speaks to their long-term growth.
Jim Cramer’s researcher, Nicole Urken, looks into what the recent stock performance of Nike and Lululemon tell us about playing earnings.
Jim Cramer’s researcher, Nicole Urken, looks into the big gain on Pharmasset and highlights some other well-positioned biotechs.
Cramer’s researcher, Nicole Urken, explains why no one tool should be relied upon when making investment decisions
Jim Cramer’s researcher, Nicole Urken, discusses how the ebullience at the NYC marathon this past weekend stands in contrast to the eurozone mood and is an analogy of the divergence in market conditions.
Jim Cramer’s researcher, Nicole Urken, explains how the team combs through the earnings reports each day and highlights upside for Deckers.
Jim Cramer and his researcher, Nicole Urken, discuss what FSLR And NFLX have in common.
Jim Cramer, and his researcher, Nicole Urken, discuss what the latest earnings from IBM, EMC and Google—and the upcoming Apple results—mean for tech.
Cramer and his researcher, Nicole Urken, discuss what the latest economic data means for positioning for the fourth quarter.
Cramer devotes a portion of Thursday’s “Mad Money” to the innovative co-founder of Apple, who passed away on Wednesday. His researcher, Nicole Urken, reflects on Jobs and his legacy.
While competition could be an issue down the road for Amazon or Apple, Cramer's researcher Nicole Urken says that doesn’t mean you can’t ride the upside in the meantime.